News

Collaboration aims to evaluate RedHill’s proprietary experimental therapy for the treatment of Ebola virus disease.

It's of 'profound' importance to proper social functioning, researchers determine.

New technology interfaces protein aggregate detection with high-throughput screening in live cells, opening new avenues to study prions, Huntington's, and other diseases.

While measuring brain activity with magnetic resonance imaging during blood pressure trials, Univeristy of California, Los Angeles (UCLA) researchers found that men and women had opposite responses in the right front of the insular cortex, a part of the brain integral to the experience of emotions, blood pressure control and self-awareness.

Research underlines importance of computational power in future neurological breakthrough.

GE’s acquisition of Biosafe Group SA further develops integrated cell therapy and regenerative medicine enabling development and patient access to innovative therapies.

Inaugural meeting, organized by InSphero AG, NCATS, CAAT, and Promega Corp., to be held Thursday, October 13, 2016 in Baltimore, MD.

Exigent announces investment in molecular diagnostic company ImmunArray who are pioneering new and more accurate ways to diagnose autoimmune diseases.

Mayo Clinic researchers identify potential immunotherapy drug combination that shows therapeutic effects against advanced and metastatic cancers.

NIH scientists identify molecule that may act as a possible treatment of neurological diseases.